CLRB
Cellectar Biosciences INC NEWRecent alerts on CLRB
All signals →
News
Cellectar plans Phase III start in late Q4 2026 as it outlines potential WM approval in the second half of 2027
19d ago
SEC filing
CLRB Reports Q1 2026 Net Loss $5.7M, $1.33 Loss per Share
19d ago
Insider trade
Purchase by James V Caruso (Chief Executive Officer)
21d ago
Insider trade
Purchase by Jarrod Longcor (Chief Operating Officer)
21d ago
News
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
123d ago
News
Dynavax President and COO Sells 114,000 Shares on Sanofi Acquisition News
123d ago
Get push alerts for CLRB
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS